NCT02939495

The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy

The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy in the Treatment of Men With Premature Ejaculation and Erectile Dysfunction (DAP-SPEED Study)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 75 (actual)
• Sponsor: Neutec Ar-Ge San ve Tic A.Ş · Industry
• Sex: Male
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Dapoxetine/Sildenafil 30/50 mg film-coated tablet in the treatment of men with premature ejaculation and erectile dysfunction.

Detailed description

During 4-weeks treatment period, patients will take one Dapoxetine/Sildenafil 30/50 mg film coated tablet 1-3 hours before sexual intercourse. Study drug should not be used more than 1 tablet every 24 hours during the treatment.

Conditions

• Premature Ejaculation
• Erectile Dysfunction

Interventions

Type	Name	Description
DRUG	Dapoxetine/Sildenafil 30/50 mg film coated tablet	1 tablet before sexual intercourse

Timeline

• Start date: 2016-10-01
• Primary completion: 2017-06-01
• Completion: 2017-08-01
• First posted: 2016-10-20
• Last updated: 2019-05-20

Locations

1 site across 1 country: Turkey (Türkiye)